BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9608484)

  • 1. Analytical approach to heterogeneity correction factor calculation for brachytherapy.
    Daskalov GM; Kirov AS; Williamson JF
    Med Phys; 1998 May; 25(5):722-35. PubMed ID: 9608484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-dimensional scatter-subtraction method for brachytherapy dose calculation near bounded heterogeneities.
    Williamson JF; Li Z; Wong JW
    Med Phys; 1993; 20(1):233-44. PubMed ID: 8455505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Monte Carlo dose calculations near 125I sources in the presence of bounded heterogeneities.
    Das RK; Keleti D; Zhu Y; Kirov AS; Meigooni AS; Williamson JF
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):843-53. PubMed ID: 9240654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities.
    Williamson JF; Perera H; Li Z; Lutz WR
    Med Phys; 1993; 20(1):209-22. PubMed ID: 8455503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sievert integral revisited: evaluation and extension to 125I, 169Yb, and 192Ir brachytherapy sources.
    Williamson JF
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1239-50. PubMed ID: 8985050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accounting for high Z shields in brachytherapy using collapsed cone superposition for scatter dose calculation.
    Tedgren AK; Ahnesjö A
    Med Phys; 2003 Aug; 30(8):2206-17. PubMed ID: 12945986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of radial dose functions for 103Pd, 125I, 145Sm, 241Am, 169Yb, 192Ir, and 137Cs brachytherapy sources.
    Meigooni AS; Nath R
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1125-30. PubMed ID: 1555964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation.
    Beaulieu L; Carlsson Tedgren A; Carrier JF; Davis SD; Mourtada F; Rivard MJ; Thomson RM; Verhaegen F; Wareing TA; Williamson JF
    Med Phys; 2012 Oct; 39(10):6208-36. PubMed ID: 23039658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dimensional scatter integration method for brachytherapy dose calculations in 3D geometry.
    Kirov AS; Williamson JF
    Phys Med Biol; 1997 Nov; 42(11):2119-35. PubMed ID: 9394401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy source characterization for improved dose calculations using primary and scatter dose separation.
    Russell KR; Tedgren AK; Ahnesjö A
    Med Phys; 2005 Sep; 32(9):2739-52. PubMed ID: 16266087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
    Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analytical dosimetry model as a step towards accounting for inhomogeneities and bounded geometries in 192Ir brachytherapy treatment planning.
    Anagnostopoulos G; Baltas D; Karaiskos P; Pantelis E; Papagiannis P; Sakelliou L
    Phys Med Biol; 2003 Jun; 48(11):1625-47. PubMed ID: 12817942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
    Chibani O; C-M Ma C
    Med Phys; 2014 May; 41(5):051712. PubMed ID: 24784378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Monte Carlo study of verification imaging in high dose rate brachytherapy.
    Sheikh-Bagheri D; Munro P
    Med Phys; 1998 Apr; 25(4):404-14. PubMed ID: 9571606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
    Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
    Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.